Metabolic Syndrome as a Risk Factor for Atrial Fibrillation in Patients with Acute Myocardial Infarction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Atrial fibrillation (AF) has been linked to an increased risk for in-hospital and long-term mortality rates in patients with acute myocardial infarction (AMI). Obesity and metabolic syndrome (MS) are known to play an important role in cardiovascular morbidity and mortality. However, it is uncertain whether obesity and MS increase the risk of AF in patients with AMI. Therefore, we investigated independent risk factors for the occurrence of new-onset AF in patients with AMI who received optimal percutaneous coronary intervention (PCI). Methods: We prospectively analyzed the association between MS and the incidence of cardiac arrhythmia in 146 patients with AMI who underwent PCI. Twenty-four-hour Holter monitoring was performed 3 days after AMI. We divided the patients into two different groups based on the development of AF and analysed their obesity based on body mass index (BMI) (kg/㎡) and evaluated the existence of MS, as well as visceral obesity with fat computed tomography. Results: Seventy-five patients (51.4%) were obese (BMI ≥ 25) and 64 (44%) had MS. AF occurred in 33 (22.6%) patients. Age, MS, and visceral obesity were significantly associated with AF (p = 0.001, p = 0.003, and p = 0.03, respectively). There was no difference between obese and non-obese patients in the incidence of AF and VT. Multivariate analysis revealed that age and MS were independent risk factors of post-AMI AF. Conclusions: MS is an important and modifiable risk factor for new-onset AF especially in patients with AMI who underwent PCI.
Abstract
Background: Atrial fibrillation (AF) has been linked to an increased risk for in-hospital and long-term mortality rates in patients with acute myocardial infarction (AMI). Obesity and metabolic syndrome (MS) are known to play an important role in cardiovascular morbidity and mortality. However, it is uncertain whether obesity and MS increase the risk of AF in patients with AMI. Therefore, we investigated independent risk factors for the occurrence of new-onset AF in patients with AMI who received optimal percutaneous coronary intervention (PCI). Methods: We prospectively analyzed the association between MS and the incidence of cardiac arrhythmia in 146 patients with AMI who underwent PCI. Twenty-four-hour Holter monitoring was performed 3 days after AMI. We divided the patients into two different groups based on the development of AF and analysed their obesity based on body mass index (BMI) (kg/㎡) and evaluated the existence of MS, as well as visceral obesity with fat computed tomography. Results: Seventy-five patients (51.4%) were obese (BMI ≥ 25) and 64 (44%) had MS. AF occurred in 33 (22.6%) patients. Age, MS, and visceral obesity were significantly associated with AF (p = 0.001, p = 0.003, and p = 0.03, respectively). There was no difference between obese and non-obese patients in the incidence of AF and VT. Multivariate analysis revealed that age and MS were independent risk factors of post-AMI AF. Conclusions: MS is an important and modifiable risk factor for new-onset AF especially in patients with AMI who underwent PCI.
참고문헌 (25)
- Al-Khatib SM, "Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial", Am J Cardiol, 88(A7), pp.76~79 (2001)
- Rathore SS, "Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes", Circulation, 101, pp.969~974 (2000)
- Mehta RH, "Primary Angioplasty in Myocardial Infarction (PAMI) Investigators: Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes", J Am Coll Cardiol, 43, pp.1765~1772 (2004)
- Kinjo K, "Osaka Acute Coronary Insufficiency Study (OACIS) Group: Prognostic significance of atrial fibrillation", atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention, 2003, pp.92, 1150~1154
- Lewis MP, "Evidence for decidua-trophoblast interactions in early human pregnancy", Hum Reprod, 8, pp.965~968 (1993)
- Pizzetti F, "GISSI-3 Investigators: Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data", Heart, 86, pp.527~532 (2001)
- Korantzopoulos P, "qAtrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress", 9, pp.225~229 (2003)
- Wanahita N, "Atrial fibrillation and obesity--results of a meta-analysis", Am Heart J, 155, pp.310~315 (2008)
- Watanabe H, "Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study", Circulation, 117, pp.1255~1260 (2008)
- Zacharias A, "Obesity and risk of new-onset atrial fibrillation after cardiac surgery", Circulation, 112, pp.3247~3255 (2005)
- Kannel WB, "Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates", Am J Cardiol, 82, pp.2N~9N (1998)
- Kühlkamp V, "Use of beta-blockers in atrial fibrillation", Am J Cardiovasc Drugs, 2, pp.37~42 (2002)
- Bourassa MG, "Angiotensin II inhibition and prevention of atrial fibrillation and stroke", J Am Coll Cardiol, 45, pp.720~721 (2005)
- Fauchier L, "Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials", J Am Coll Cardiol, 51, pp.828~835 (2008)
- "WHO Expert Consultation: Appropriate body-mass index for Asian population and its implication for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
- Page RL, "Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia", Circulation, 89, pp.224~227 (1994)
- Fujioka S, "Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity", Metabolism, 36, pp.54~59 (1987)
- Go AS, "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study", JAMA, 285, pp.2370~2375 (2001)
- Kipshidze NN, "Effect of the metabolic syndrome on the electrophysiological parameters of the heart", Georgian Med News, 119, pp.9~13 (2005)
- Leaf A, "Plasma nonesterified fatty acid concentration as a risk factor for sudden cardiac death: the Paris Prospective Study", Circulation, 104, pp.744~745 (2001)
- Pritchett AM, "Left atrial volume as an index of left atrial size: a population-based study", J Am Coll Cardiol, 41, pp.1036~1043 (2003)
- Vincent HK, "Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord", 23, pp.67~74 (1999)
- Powell BD, "Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease", Am J Cardiol, 98, pp.116~120 (2006)
- Henkel DM, "Ventricular arrhythmias after acute myocardial infarction: a 20-year community study", Am Heart J, 151, pp.806~812 (2006)
- Hohnloser SH, "Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era", J Am Coll Cardiol, 33, pp.1895~1902 (1999)